Heparin-enriched plasma proteome is significantly altered in Alzheimer's Disease.
Qi GuoLingyan PingEric B DammerLuming YinKaiming XuAnantharaman ShantaramanEdward J FoxTodd E GoldeErik C B JohnsonBlaine R RobertsJames J LahAllan I LeveyNicholas T SeyfriedPublished in: Research square (2024)
These findings support the utility of a heparin-affinity approach for enriching amyloid-associated proteins, as well as a wide spectrum of plasma biomarkers that reflect pathological changes in the AD brain.